Why Pharma NPD Projects Struggle – and How Digital Governance Improves Execution

Pharma NPD digital governance is becoming essential as New Product Development programmes grow across functions, partners and regulatory markets. The science may be sound, yet projects still lose time when milestones, hand-offs, decisions and ownership are managed through disconnected spreadsheets, emails and review meetings.

A molecule can clear technical hurdles in the lab and still stall because a hand-off between R&D and Manufacturing is informal, a study dependency is identified late, a regulatory action is buried in an email, or nobody has a consolidated view of what is holding the product back.

The problem is often governance, not science

Pharma NPD is not one project stream. Development, analytical work, manufacturing, bioequivalence studies, clinical studies, regulatory submissions, packaging and commercial readiness can move in parallel while remaining highly dependent on one another.

When each function maintains its own tracker, management may see activity without seeing the real project picture. A task can appear green within one function while the overall product milestone is already at risk.

Fragmented tracking → Hidden dependencies → Late decisions → Milestone slippage → Delayed market readiness

Digital governance starts with visibility

A digital governance framework does not replace scientific judgement or specialist systems. It establishes a common management layer: defined owners, visible milestones, dependencies, exceptions and decision points across the NPD lifecycle.

The first step does not need to be a large enterprise platform. Focused digital trackers can bring discipline to critical workstreams and gradually create a connected NPD view.

1. CRO Tracker for BE Studies

A Bioequivalence (BE) study tracker can provide one management view of study planning and execution: study/CRO ownership, key dates, dependencies, approvals, study milestones, report status and open actions. The objective is not to replace the scientific study system. It is to make schedule risk and ownership visible to the NPD team.

2. CRO Tracker for Clinical Trials

A Clinical Trial (CT) study tracker can bring together major study milestones, responsibilities, submissions, CRO/site actions, dependencies and exceptions. Project teams can focus reviews on delayed or at-risk items instead of manually reconciling status from several sources.

3. Regulatory Affairs Tracker

An RA tracker can provide country-wise visibility of filings, agency queries, response deadlines, approvals, renewals and variations. For products moving across multiple markets, this turns regulatory activity into a visible programme of milestones rather than a collection of independent spreadsheets.

The real value comes when the trackers connect

BE, CT and RA trackers should not become three new digital silos. Their value increases when critical milestones and exceptions roll into the same NPD governance view.

• One accountable owner for every critical milestone.
• Visible dependencies between studies, regulatory actions and downstream activities.
• Exception-based reviews focused on red and amber items.
• Decision visibility so unresolved issues do not remain hidden between functions.
• One management picture showing where each product stands and what is threatening the next milestone.

Digitalisation should strengthen governance

The goal is not to digitise every spreadsheet. It is to decide which information management needs to govern the NPD programme: milestones, ownership, dependencies, decisions, exceptions and readiness.

Start with the workstreams where lack of visibility creates the greatest project risk. A CRO Tracker (for BE studies and clinical trials) or an RA Tracker can be a practical entry point. The longer-term objective is a connected governance framework across Concept to Commercialization.

Where PMSoft Pharma helps

PMSoft Pharma combines pharma project-management discipline with practical digitalisation. We help teams map the current process, identify governance gaps and design focused digital trackers and management views around the tools and processes the organisation already uses.

The starting question is simple: Where is your NPD programme losing visibility today?